Collaborations and publications
2013
Genes for blood pressure: an opportunity to understand hypertension. Ehret GB and Caulfield M. Eur Heart J. 2013[1]
2012
Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension. Hum Mol Genet. 2012 Jul 15;21(14):3283-92. Guessous I, Dobrinas M, Kutalik Z, Pruijm M, Ehret G, Maillard M, Bergmann S, Beckmann JS, Cusi D, Rizzi F, Cappuccio F, Cornuz J, Paccaud F, Mooser V, Gaspoz JM, Waeber G, Burnier M, Vollenweider P, Eap CB, Bochud M.[2]
A multi-SNP locus-association method reveals a substantial fraction of the missing heritability. Ehret GB, Lamparter D, Hoggart CJ; Genetic Investigation of Anthropometric Traits Consortium, Whittaker JC, Beckmann JS, Kutalik Z.Am J Hum Genet. 2012 Nov 2;91(5):863-71.[3]
2011
Bochud M. et al., Eur J Public Health. 2011 Feb;21(1):5-6.[4]
Guessous I et al, Kidney Blood Press Res. 2011 Jun 11;34(6):404-417.[5]
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Ehret GB, Munroe PB, Rice KM, Bochud M et al. Nature. 2011 Sep 11;478(7367):103-9.[6]
2010
Pruijm M et al, Blood Press Monit. 2010 Dec;15(6):322-5.[7]
Resistant Hypertension. Ehret GB, Pechère-Bertschi A. Rev Med Suisse. 2010 Sep 15;6(262):1721-2, 1724-7. [8]
Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Ehret GB. Curr Hypertens Rep. 2010 Feb;12(1):17-25.[9]
